Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 31.00
Ask: 34.00
Change: 0.00 (0.00%)
Spread: 3.00 (9.677%)
Open: 32.50
High: 32.50
Low: 32.50
Prev. Close: 32.50
TPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of new Group company, TPX human+

26 Feb 2019 07:00

RNS Number : 0691R
Panoply Holdings PLC (The)
26 February 2019
 

26 February 2019

RNS Reach

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Launch of new Group company, TPX human+

TPX Notbinary launches Robotic Process Automation subsidiary

 

The Panoply Holdings PLC, the digitally native technology services Group, is delighted to announce the launch of TPX human+, a specialist robotic process automation ("RPA") business. TPX human+ has been set up as a subsidiary of TPX Notbinary, one of The Panoply's existing Group companies.

 

TPX human+ is a provider of robotic process automation services, primarily to the government and not for profit industries. The business has developed organically in response to strong demand from TPX Notbinary's existing customer base, and marks The Panoply's entry into the RPA market, further building out the UK Cluster's set of digital transformation capabilities. Gartner estimates the worldwide market size of RPA C&SI services was $1.5 billion in 2017, growing at over 50% year over year.

 

The Group has entered into strategic partnerships with Blue Prism, UiPath and Thougtonomy, and TPX human+ will act as an implementation partner to these software vendors as well as providing other related consultancy services. Government and not for profit organisations are increasingly looking at the benefits RPA can bring following the uptake being seen in the private sector.

 

The Panoply is investing into TPX human+ in line with its strategy to back start-ups with strong management and strong potential for growth. As a subsidiary of TPX Notbinary TPX human+ will be subject to the TPX Notbinary earn-out formula which runs until 31 March 2020.

 

TPX human+ will be led by David Biden and Ciara MacCooey, who both have a wealth of experience in applying modern technologies into complex business environments. TPX human+ currently has proof-of-concept projects active with a number of large clients, including a university, a county council and a not for profit organisation. TPX human+ are confident that the Group's existing client base and reputation in the government and not for profit sectors will allow them to quickly gain a foothold in the RPA market.

 

Neal Gandhi, Chief Executive Officer of The Panoply said:

 

"We know that the demand for RPA services is growing rapidly, and for some time this has been a competency that we have been looking to own within The Panoply. TPX human+ takes an approach which puts the focus on engaging the business stakeholders involved; implementing the right technology and enabling the humans central to its adoption.

 

"This is the first example of The Panoply having chosen to support the organic growth of a business which has originated from within a current Group company. Allowing our Group companies to remain entrepreneurial and creative has always been a core tenant of The Panoply proposition, and we are excited to see this playing out in reality with the incorporation of TPX human+."

 

David Biden, Founding Partner at TPX human+ said:

 

"TPX human+ is being launched in response to our government and not for profit clients wanting an automation partner that not only understands RPA technology but also the impact this can have on their organisations and people. We are seeing great interest from across the Public Sector and the not for profit community as we work with them to understand the efficiency opportunities this technology can bring."

 

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

Neil Shah

Luisa Orsini Baroni

 

 

 

Alma PR

(Financial PR)

Josh Royston

Susie Hudson

panoply@almapr.co.uk

+44(0)203 405 0206

07780 901979

 

 

 

About The Panoply

 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology and innovation consulting businesses across Europe, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

 

Visit https://www.thepanoply.com for more information

 

About TPX human+

 

TPX human+ is a robotic process automation partner for government and not for profit organisations. The company's mission is to drive RPA success through engaging business stakeholders, implementing the right technology and enabling the humans central to its adoption. TPX human+ drives efficiencies across the organisation with the goal of creating a self-sufficient centre of excellence for the future, and helping people focus on more interesting, business-critical work.

 

TPX human+ partners with RPA leaders such as Blue Prism, Thoughtonomy and UiPath. As a subsidiary of TPX Notbinary, the company has a strong track record in Government and not for profit technology transformation projects.

 

Visit http://human-plus.co.uk/ for more information

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAPASAFXNEFF
Date   Source Headline
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m
14th Sep 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th Sep 20231:05 pmRNSUpdate on Current Trading and Notice of AGM
25th Aug 20231:03 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.